Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Christineh N, Sarkissian"'
Publikováno v:
Molecular Genetics and Metabolism. 137:388-398
Charles Scriver is a towering figure in the medical genetics community. At 92 he can look back upon a remarkable career that established the field of biochemical genetics, a subsection of medical genetics that is translating the developments in basic
Publikováno v:
Journal of Inherited Metabolic Disease.
Autor:
Beat Thöny, Hiu Man Grisch-Chan, Ming Ying, Gabriella Allegri, Cary O. Harding, Shelley R. Winn, Tanja Scherer, Aurora Martinez, Christineh N. Sarkissian, Anahita Rassi
Hyperphenylalaninemia (HPA) caused by hepatic phenylalanine hydroxylase (PAH) deficiency has severe consequences on brain monoamine neurotransmitter metabolism. We have studied monoamine neurotransmitter status and the effect of tetrahydrobiopterin (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f92edb62e1953d35156c94acf0c61b4
https://www.zora.uzh.ch/id/eprint/165254/
https://www.zora.uzh.ch/id/eprint/165254/
Phenylalanine ammonia lyase (PAL): From discovery to enzyme substitution therapy for phenylketonuria
Publikováno v:
Molecular genetics and metabolism. 124(4)
Phenylketonuria (PKU) is a genetic inborn error in metabolism that impacts many people globally, with profound individual and societal consequences when left untreated. The journey of phenylalanine ammonia lyase (PAL) from plant enzyme to enzyme subs
Autor:
Raymond C. Stevens, Alejandra Gámez, Tse Siang Kang, Charles R. Scriver, Christineh N. Sarkissian
Publikováno v:
Molecular Genetics and Metabolism. 104:249-254
Phenylketonuria (PKU), a Mendelian autosomal recessive phenotype (OMIM 261600), is an inborn error of metabolism causing impaired postnatal cognitive development in the absence of treatment. We used the Pahenu2/enu2 PKU mouse model to study oral enzy
Autor:
Tse Siang Kang, Charles R. Scriver, Raymond C. Stevens, Christineh N. Sarkissian, Alejandra Gámez, Lin Wang
Publikováno v:
Molecular Genetics and Metabolism. 99:4-9
Phenylalanine ammonia lyase (PAL) has long been recognized as a potential enzyme replacement therapeutic for treatment of phenylketonuria. However, various strategies for the oral delivery of PAL have been complicated by the low intestinal pH, aggres
Autor:
Jeffrey F. Lemontt, Laurie Tsuruda, Raymond C. Stevens, Christineh N. Sarkissian, Bin Zhao, Amy Lambert, Carroll Henschell, Marilyse Charbonneau, Charles R. Scriver, Paul F. Fitzpatrick, Michael Vellard, Sean M. Bell, Alejandra Gámez, Lin Wang
Publikováno v:
Proceedings of the National Academy of Sciences. 105:20894-20899
Phenylketonuria (PKU) is a metabolic disorder, in which loss of phenylalanine hydroxylase activity results in neurotoxic levels of phenylalanine. We used the Pah enu2/enu2 PKU mouse model in short- and long-term studies of enzyme substitution therapy
Publikováno v:
Journal of Mass Spectrometry. 42:811-817
We describe a sensitive, simple and convenient stable isotope dilution assay developed to study endogenous metabolism of administered stable isotope-labeled phenylalanine (Phe) in phenylketonuric (PKU) mice treated experimentally with phenylalanine a
Publikováno v:
Molecular Genetics and Metabolism. 86:22-26
Phenylketonuria (PKU) is an autosomal recessive genetic disorder in which mutations in the phenylalanine-4-hydroxylase (PAH) gene result in an inactive enzyme (PAH, EC 1.14.16.1). The effect is an inability to metabolize phenylalanine (Phe), translat
Autor:
Christineh N. Sarkissian, Lynne Prevost, Mélarnie Hurtubise, Paula J. Waters, Shannon Ryan, David Konecki, Raymond C. Stevens, Manyphong Phommarinh, Charles R. Scriver, David Mcdonald, Heidi Erlandsen
Publikováno v:
Human Mutation. 21:333-344
PAHdb, a legacy of and resource in genetics, is a relational locus-specific database (http://www.pahdb.mcgill.ca). It records and annotates both pathogenic alleles (n = 439, putative disease-causing) and benign alleles (n = 41, putative untranslated